Two-level cervical disc arthroplasty versus anterior cervical discectomy and fusion: 10-year outcomes of a prospective, randomized investigational device exemption clinical trial.

Gornet, Matthew F; Lanman, Todd H; Burkus, J Kenneth; Dryer, Randall F; McConnell, Jeffrey R; Hodges, Scott D; Schranck, Francine W

Gornet, Matthew F; Lanman, Todd H; Burkus, J Kenneth; Dryer, Randall F; McConnell, Jeffrey R; Hodges, Scott D; Schranck, Francine W.

Gornet MF; 1The Orthopedic Center of St. Louis, St. Louis, Missouri.
Lanman TH; 2Institute for Spinal Disorders, Cedars-Sinai Medical Center, Los Angeles, California.
Burkus JK; 3Wilderness Spine Services, Columbus, Georgia.
Dryer RF; 4Central Texas Spine Institute, Austin, Texas.
McConnell JR; 5Orthopedic Specialists, Allentown, Pennsylvania.
Hodges SD; 6Center for Sports Medicine & Orthopaedics, Chattanooga, Tennessee; and.
Schranck FW; 7SPIRITT Research, St. Louis, Missouri.

J Neurosurg Spine ; : 1-11, 2019 Jun 21.

Article en En | MEDLINE | ID: mdl-31226684

Palabras clave

ACDF; ACDF = anterior cervical discectomy and fusion; AE = adverse event; BCI = Bayesian credible interval; CDA = cervical disc arthroplasty; DDD = degenerative disc disease; FSU = functional spinal unit; HO = heterotopic ossification; HPD = highest posterior density; IDE = investigational device exemption; LHR = log hazard ratio; MCS = Mental Component Summary of SF-36; NDI = Neck Disability Index; PAS = postapproval study; PCS = Physical Component Summary of SF-36; PPS = posterior probability of superiority; Prestige LP disc replacement; ROM = range of motion; TDR = total disc replacement; anterior cervical discectomy and fusion; artificial cervical disc; cTDR = cervical TDR; cervical degenerative disc disease; cervical disc arthroplasty; myelopathy; radiculopathy; two-level disc disease

Texto completo

Imprimir

XML

PubMed Links

Search on Google